article thumbnail

Merck opens $1B vaccine plant in North Carolina

Bio Pharma Dive

Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S.

article thumbnail

California’s low-cost insulin plans receive $100m manufacturing boost

Pharmaceutical Technology

Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.

Insulin 328
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Incannex partners with Catalent to manufacture psilocybin

Pharmaceutical Technology

Incannex Healthcare has collaborated with New Jersey-based pharma company Catalent for the development and manufacturing of a cGMP-grade psilocybin drug product for clinical trials and potential commercial use. It will also establish cGMP manufacturing of a drug product which will be utilised in future clinical trials.

article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

article thumbnail

Eczac?ba?? to acquire Turkish pharma company Gensenta for $135m

Pharmaceutical Technology

Gensenta is a major manufacturer of finished pharmaceuticals and active ingredients in Turkey and is the key producer and exporter of lyophilized vials in the region. In addition, the company produces penicillin, Etodolac and various other active ingredients at its pharmaceutical ingredient manufacturing plant. The post Eczac?ba??

article thumbnail

Samsung Biologics and European pharma company enter major manufacturing deal

BioPharma Reporter

The global CDMO has entered into several high-value manufacturing deals this year.

article thumbnail

Samsung Biologics and European pharma company enter major manufacturing deal

BioPharma Reporter

The global CDMO has entered into several high-value manufacturing deals this year.